Cargando…
miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy
Duchenne Muscular Dystrophy (DMD) is a lethal muscle disorder, caused by mutations in the DMD gene and affects approximately 1:5000–6000 male births. In this report, we identified dysregulation of members of the Dlk1-Dio3 miRNA cluster in muscle biopsies of the GRMD dog model. Of these, we selected...
Autores principales: | Sanson, M., Vu Hong, A., Massourides, E., Bourg, N., Suel, L., Amor, F., Corre, G., Bénit, P., Barthélémy, I., Blot, S., Bigot, A., Pinset, C., Rustin, P., Servais, L., Voit, T., Richard, I., Israeli, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272451/ https://www.ncbi.nlm.nih.gov/pubmed/32499563 http://dx.doi.org/10.1038/s41598-020-66016-7 |
Ejemplares similares
-
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
por: Amor, Fatima, et al.
Publicado: (2021) -
Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2022) -
A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2021) -
Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2020) -
Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
por: Barthélémy, Inès, et al.
Publicado: (2014)